Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Sied Kebir(University of Bonn), Björn Scheffler(German Cancer Research Center), Guido Reifenberger(German Cancer Research Center), Verena Jendrossek(University of Duisburg-Essen), Franziska K. Lorbeer(Research Institute of Molecular Pathology), Michael Weller(University of Zurich), Frank K.H. van Landeghem(University of Alberta), Christel Herold‐Mende, Barbara M. Grüner(West German Heart and Vascular Center Essen), Oliver Brüstle(University of Bonn), Alexander Roesch(University of Regensburg), Tobias Blau(University of Duisburg-Essen), Matthias Simon(University of Bonn), Timo Wilhelm-Buchstab(University of Bonn), Igor Cima(Deutsches Konsortium für Translationale Krebsforschung), Anja Wieland(University of Bonn), Johann Matschke(University of Duisburg-Essen), Marc Remke(Düsseldorf University Hospital), Pia Berger(German Cancer Research Center), Daniel Trageser(University of Bonn), Kathy Keyvani(Essen University Hospital), Torsten Pietsch(University of Bonn), Ulrich Sure(University of Duisburg-Essen), Holger Fröhlich(University of Bonn), Jörg Felsberg(Heinrich Heine University Düsseldorf), Jens T. Siveke(German Cancer Research Center), Vivien Ullrich(German Cancer Research Center), Laurèl Rauschenbach(University of Bonn), Andreas Till(University of Bonn), Shruthi Prasad(German Cancer Research Center), Sarah Langer(German Cancer Research Center), Martin Glas(University of Bonn), Celia Dobersalske(Düsseldorf University Hospital), Ashar Ahmad(University of Bonn)
Cited by 0
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k